Predictive Marker in malignant Melanoma

被引：0
|
作者：
Weide, B. [1 ]
机构：
[1] Univ Hautklin Tubingen, Tubingen, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2017年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
S01/02
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [1] The use erythrocyte glutathione as a predictive marker for malignant melanoma
    Moral, A
    Lafuente, MJ
    Lafuente, A
    Castel, T
    Balesta, AM
    Trias, MLM
    ANTICANCER RESEARCH, 2000, 20 (6C) : 4757 - 4760
  • [2] Methylthioadenosine phosphorylase is a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma
    Meyer, S.
    Wild, P.
    Vogt, T.
    Bataille, F.
    Ehret, C.
    Landthaler, M.
    Hofstaedter, F.
    Bosserhoff, A. K.
    EXPERIMENTAL DERMATOLOGY, 2009, 18 (03) : 309 - 309
  • [3] XIAP as a prognostic marker for Malignant Melanoma
    Emanuel, PO
    Shafir, M
    Burstein, DE
    Mudgil, A
    Phelps, RG
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 71 - 72
  • [4] MIA, a serological marker of malignant melanoma
    Bosserhoff, AK
    Hein, R
    Dreau, D
    Stolz, W
    Landthaler, M
    Buettner, R
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (03) : 515 - 515
  • [5] Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma
    Meyer, Stefanie
    Wild, Peter J.
    Vogt, Thomas
    Bataille, Frauke
    Ehret, Christoph
    Gantner, Susanne
    Landthaler, Michael
    Klinkhammer-Schalke, Monika
    Hofstaedter, Ferdinand
    Bosserhoff, Anja K.
    EXPERIMENTAL DERMATOLOGY, 2010, 19 (08) : E251 - E257
  • [6] Melanoma inhibitory activity (MIA), a serological marker of malignant melanoma
    Bosserhoff, AK
    Dreau, D
    Hein, R
    Landthaler, M
    Holder, WD
    Buettner, R
    MINIMAL RESIDUAL DISEASE IN MELANOMA: BIOLOGY, DETECTION AND CLINICAL RELEVANCE, 2001, 158 : 158 - 168
  • [7] Serum 5-S-cysteinyl-dopa levels as a predictive marker for the efficacy of nivolumab in advanced malignant melanoma
    Umemura, Hiroshi
    Kaji, Tatsuya
    Tachibana, Kota
    Morizane, Shin
    Yamasaki, Osamu
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2019, 34 (04): : 414 - 420
  • [8] Novel prognostic marker proteins for malignant melanoma immunotherapy
    Krebs, F.
    Hahn, S.
    Mitzel, H.
    Jetter, A.
    Behling, J.
    Wickert, D.
    Lang, B.
    Meissner, M.
    Tenzer, S.
    Grabbe, S.
    Loquai, C.
    Tuettenberg, A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 23 - 23
  • [9] MIA, a novel serum marker for progression of malignant melanoma
    Bosserhoff, AK
    Lederer, M
    Kaufmann, M
    Hein, R
    Stolz, W
    Apfel, R
    Bogdahn, U
    Buettner, R
    ANTICANCER RESEARCH, 1999, 19 (4A) : 2691 - 2693
  • [10] Invasive Breadth as a Novel Prognostic Marker for Malignant Melanoma
    Khanna, A.
    Bamford, M.
    Saldanha, G. S.
    JOURNAL OF PATHOLOGY, 2019, 249 : S11 - S11
12345